The huge acquisition of "Pharmaceutical Headline Jun" led to the early retirement of some of Takeda's employees.

(2020/08/19) Domestic innovative drugs will compete with foreign star products for medical insurance eligibility more than 20 drugs will be shortlisted; ADC drug research and development of the key four elements and development trends; private hospitals the first collapse: cut vegetables to buy the billion empire is finally to return ... (Click on the title to get the original version) "The Hangouts" of the $59 billion acquisition continues Takeda's new "slimming campaign" last year, when Takeda completed its $59 billion acquisition of Shire.
the huge merger has led to a restructuring of the company, which continues to this day, even hurting Takeda's local operations in Japan.
August 18, Takeda announced that it would provide "early retirement" services to Japanese employees.
so-called "future career plan" will be aimed at sales and administration, but not the research and development or manufacturing business, the Nikkei Asia Review reported.
headline: Takeda is trying to get rid of Japan's traditional tenure.
"E drug manager" domestic innovative drugs will compete with foreign star products for medical insurance qualification more than 20 drugs will be shortlisted on August 17, the State Health Insurance Administration released the official version of the 2020 National Health Insurance Drug Catalog Adjustment Work Programme.
previously, from August 3 to 10, the National Health Insurance Administration sought advice from the community on this year's health-care catalog adjustment, and after the release of the official document, the biggest change was the admission of a new version of the 2020 drug declaration catalogue.
: PD-1/L1 pattern is more complex.
The key four elements of drug development and development trends of ADC ADC ADC (antibody-drugconjugates) technology is to connect monoantigen and drug molecules by linker, using antibody specific target transport drug molecules to the target tissue to play a role, reduce the systemic toxic side effects of drugs, improve the drug treatment window and expand the potential of antibody therapy.
: The successful development of ADC relies on the specific binding of antibodies to target antigens.
"Eight o'clock health" private hospital first stock crash: cut vegetables to buy the 10 billion empire is finally to return to the summer of 2015, with herbal-based Hengkang Medical market value reached an unprecedented 34.6 billion yuan, by the capital market as the first private hospital shares.
know that China Resources Healthcare, which is backed by SASAC and has more than 100 medical facilities, has a market capitalisation of just HK$16.5 billion at its highest.
headline: The greed of human nature never ends.
.